Mission Creek Capital Partners’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-6,511
Closed -$200K 209
2020
Q3
$200K Buy
+6,511
New +$200K 0.08% 196